Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin as an Anticancer Agent
Aleš Vančura, Pengli Bu, Madhura Bhagwat, et al.
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 10, pp. 867-878
Open Access | Times Cited: 234

Showing 1-25 of 234 citing articles:

Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Jiajie Hou, Michael Karin, Beicheng Sun
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 261-279
Open Access | Times Cited: 261
Role of Mitochondria in the Mechanism(s) of Action of Metformin
Guillaume Vial, Dominique Détaille, Bruno Guigas
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 250
Metformin as Anti-Aging Therapy: Is It for Everyone?
Alexander A. Soukas, Haibin Hao, Lianfeng Wu
Trends in Endocrinology and Metabolism (2019) Vol. 30, Iss. 10, pp. 745-755
Open Access | Times Cited: 203
A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan
Ibrahim Mohammed, Morley D. Hollenberg, Hong Ding, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 194
Metformin: Is it a drug for all reasons and diseases?
Chris R. Triggle, Ibrahim Mohammed, Khalifa Bshesh, et al.
Metabolism (2022) Vol. 133, pp. 155223-155223
Open Access | Times Cited: 182
Obesity, Diabetes, and Increased Cancer Progression
Dae-Seok Kim, Philipp E. Scherer
Diabetes & Metabolism Journal (2021) Vol. 45, Iss. 6, pp. 799-812
Open Access | Times Cited: 162
Oncometabolites in renal cancer
Cissy Yong, Grant D. Stewart, Christian Frezza
Nature Reviews Nephrology (2019) Vol. 16, Iss. 3, pp. 156-172
Open Access | Times Cited: 156
Metabolic reprogramming in prostate cancer
Fahim Ahmad, Murali Cherukuri, Peter L. Choyke
British Journal of Cancer (2021) Vol. 125, Iss. 9, pp. 1185-1196
Open Access | Times Cited: 135
Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms
Sheng Chen, Donghao Gan, Sixiong Lin, et al.
Theranostics (2022) Vol. 12, Iss. 6, pp. 2722-2740
Open Access | Times Cited: 110
Mitochondria as an important target of metformin: The mechanism of action, toxic and side effects, and new therapeutic applications
Jin Feng, Xiaohui Wang, Xiaochun Ye, et al.
Pharmacological Research (2022) Vol. 177, pp. 106114-106114
Closed Access | Times Cited: 101
Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Hua Yu, Yue Zheng, Yiran Yao, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 93
Antiaging agents: safe interventions to slow aging and healthy life span extension
Ji‐Kai Liu
Natural Products and Bioprospecting (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 70
Metformin acts in the gut and induces gut-liver crosstalk
Natália Tobar, Guilherme Z. Rocha, Andrey Santos, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 4
Open Access | Times Cited: 43
Metformin-based nanomedicines for reprogramming tumor immune microenvironment
Jieyu Liu, Xiaoling Li, Yinggang Li, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 993-1016
Closed Access | Times Cited: 28
Self-Adjuvanting Polyguanidine Nanovaccines for Cancer Immunotherapy
Xuanbo Zhang, Kaiyuan Wang, Zhiqiang Zhao, et al.
ACS Nano (2024) Vol. 18, Iss. 9, pp. 7136-7147
Closed Access | Times Cited: 17
Examining the clinical relevance of metformin as an antioxidant intervention
Angelika Buczyńska, Iwona Sidorkiewicz, Adam Krętowski, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 16
Tumour metabolism and its unique properties in prostate adenocarcinoma
David Bader, Sean E. McGuire
Nature Reviews Urology (2020) Vol. 17, Iss. 4, pp. 214-231
Closed Access | Times Cited: 119
The Current and Potential Therapeutic Use of Metformin—The Good Old Drug
Józef Drzewoski, M Hanefeld
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 122-122
Open Access | Times Cited: 101
Insulin Resistance and Cancer: In Search for a Causal Link
Eusebio Chiefari, Maria Mirabelli, Sandro La Vignera, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11137-11137
Open Access | Times Cited: 86
Accelerated bio‐cognitive aging in Down syndrome: State of the art and possible deceleration strategies
Claudio Franceschi, Paolo Garagnani, Noémie Gensous, et al.
Aging Cell (2019) Vol. 18, Iss. 3
Open Access | Times Cited: 77
Metformin: An old drug against old age and associated morbidities
Teresa Salvatore, Pia Clara Pafundi, Floriana Morgillo, et al.
Diabetes Research and Clinical Practice (2020) Vol. 160, pp. 108025-108025
Closed Access | Times Cited: 74
Metformin suppresses the growth of colorectal cancer by targeting INHBA to inhibit TGF-β/PI3K/AKT signaling transduction
Qing Xiao, Jiani Xiao, Jiaqi Liu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 55
An injectable and pH-responsive hyaluronic acid hydrogel as metformin carrier for prevention of breast cancer recurrence
Zexiang Zheng, Xing Yang, Yifan Zhang, et al.
Carbohydrate Polymers (2022) Vol. 304, pp. 120493-120493
Closed Access | Times Cited: 46
Design and fabrication of a dual-drug loaded nano-platform for synergistic anticancer and cytotoxicity effects on the expression of leptin in lung cancer treatment
Yalda Alagheband, Davoud Jafari-Gharabaghlou, Mahsa Imani, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 73, pp. 103389-103389
Closed Access | Times Cited: 44
Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application
Davoud Jafari-Gharabaghlou, Mehdi Dadashpour, Omid Joodi Khanghah, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 4, pp. 3023-3033
Closed Access | Times Cited: 34
Page 1 - Next Page

Scroll to top